Literature DB >> 9326321

Deletion of RB exons 24 and 25 causes low-penetrance retinoblastoma.

R Bremner1, D C Du, M J Connolly-Wilson, P Bridge, K F Ahmad, H Mostachfi, D Rushlow, J M Dunn, B L Gallie.   

Abstract

A deletion in the tumor-suppressor gene, RB, discovered by quantitative multiplex PCR, shows low penetrance (LP), since only 39% of eyes at risk in this family develop retinoblastoma. The 4-kb deletion spanning exons 24 and 25 (delta24-25) is the largest ever observed in an LP retinoblastoma family. Unlike the usual RB mutations, which cause retinoblastoma in 95% of at-risk eyes and yield no detectable protein, the delta24-25 allele transcribed a message splicing exon 23 to exon 26, resulting in a detectable protein (pRBdelta24-25) that lacks 58 amino acids from the C-terminal domain, proving that this domain is essential for suppression of retinoblastoma. Two functions were partially impaired by delta24-25-nuclear localization and repression of E2F-consistent with the idea that LP mutations generate "weak alleles" by reducing but not eliminating essential activities. However, delta24-25 ablated interaction of pRB with MDM2. Since a homozygous LP allele is considered nontumorigenic, the pRB/MDM2 interaction may be semi- or nonessential for suppressing retinoblastoma. Alternatively, some homozygous LP alleles may not cause tumorigenesis because an additional event is required (the "three-hit hypothesis"), or the resulting imbalance in pRB function may cause apoptosis (the "death allele hypothesis"). pRBdelta24-25 was also completely defective in suppressing growth of Saos-2 osteosarcoma cells. Targeting pRBdelta24-25 to the nucleus did not improve Saos-2 growth suppression, suggesting that C-terminal domain functions other than nuclear localization are essential for blocking proliferation in these cells. Since delta24-25 behaves like a null allele in these cells but like an LP allele in the retina, pRB may use different mechanisms to control growth in different cell types.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9326321      PMCID: PMC1715941          DOI: 10.1086/515499

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  117 in total

1.  Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein.

Authors:  L Zhu; S van den Heuvel; K Helin; A Fattaey; M Ewen; D Livingston; N Dyson; E Harlow
Journal:  Genes Dev       Date:  1993-07       Impact factor: 11.361

2.  Paternal selection favoring mutant alleles of the retinoblastoma susceptibility gene.

Authors:  F Munier; M A Spence; G Pescia; A Balmer; C Gailloud; F Thonney; G van Melle; H P Rutz
Journal:  Hum Genet       Date:  1992-07       Impact factor: 4.132

3.  Amplification of a gene encoding a p53-associated protein in human sarcomas.

Authors:  J D Oliner; K W Kinzler; P S Meltzer; D L George; B Vogelstein
Journal:  Nature       Date:  1992-07-02       Impact factor: 49.962

4.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

5.  Molecular mechanisms of oncogenic mutations in tumors from patients with bilateral and unilateral retinoblastoma.

Authors:  A Hogg; B Bia; Z Onadim; J K Cowell
Journal:  Proc Natl Acad Sci U S A       Date:  1993-08-01       Impact factor: 11.205

6.  Distinct RB1 gene mutations with low penetrance in hereditary retinoblastoma.

Authors:  D R Lohmann; B Brandt; W Höpping; E Passarge; B Horsthemke
Journal:  Hum Genet       Date:  1994-10       Impact factor: 4.132

7.  Mutation and cancer: statistical study of retinoblastoma.

Authors:  A G Knudson
Journal:  Proc Natl Acad Sci U S A       Date:  1971-04       Impact factor: 11.205

8.  MDM2 gene amplification in metastatic osteosarcoma.

Authors:  M Ladanyi; C Cha; R Lewis; S C Jhanwar; A G Huvos; J H Healey
Journal:  Cancer Res       Date:  1993-01-01       Impact factor: 12.701

9.  Retinoma: spontaneous regression of retinoblastoma or benign manifestation of the mutation?

Authors:  B L Gallie; R M Ellsworth; D H Abramson; R A Phillips
Journal:  Br J Cancer       Date:  1982-04       Impact factor: 7.640

10.  Second primary neoplasms in patients with retinoblastoma.

Authors:  G J Draper; B M Sanders; J E Kingston
Journal:  Br J Cancer       Date:  1986-05       Impact factor: 7.640

View more
  21 in total

1.  A parent-of-origin effect in two families with retinoblastoma is associated with a distinct splice mutation in the RB1 gene.

Authors:  Martina Klutz; Dieter Brockmann; Dietmar R Lohmann
Journal:  Am J Hum Genet       Date:  2002-05-09       Impact factor: 11.025

2.  Acetylation of Rb by PCAF is required for nuclear localization and keratinocyte differentiation.

Authors:  Adam Pickard; Ping-Pui Wong; Dennis J McCance
Journal:  J Cell Sci       Date:  2010-10-12       Impact factor: 5.285

3.  Rb1/105 gene alterations and head and neck carcinogenesis.

Authors:  Maimoona Sabir; Ruqia Mehmood Baig; Ishrat Mahjabeen; Muhammad Saeed; Faraz Arshad Malik; Mahmood Akhtar Kayani
Journal:  Mol Biol Rep       Date:  2012-06-29       Impact factor: 2.316

4.  An RB-EZH2 Complex Mediates Silencing of Repetitive DNA Sequences.

Authors:  Charles A Ishak; Aren E Marshall; Daniel T Passos; Carlee R White; Seung J Kim; Matthew J Cecchini; Sara Ferwati; William A MacDonald; Christopher J Howlett; Ian D Welch; Seth M Rubin; Mellissa R W Mann; Frederick A Dick
Journal:  Mol Cell       Date:  2016-11-23       Impact factor: 17.970

Review 5.  Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.

Authors:  David N Cooper; Michael Krawczak; Constantin Polychronakos; Chris Tyler-Smith; Hildegard Kehrer-Sawatzki
Journal:  Hum Genet       Date:  2013-07-03       Impact factor: 4.132

6.  Parent-of-origin effect of hypomorphic pathogenic variants and somatic mosaicism impact on phenotypic expression of retinoblastoma.

Authors:  Valentina Imperatore; Anna Maria Pinto; Elisa Gelli; Eva Trevisson; Valeria Morbidoni; Elisa Frullanti; Theodora Hadjistilianou; Sonia De Francesco; Paolo Toti; Elena Gusson; Gaia Roversi; Andrea Accogli; Valeria Capra; Maria Antonietta Mencarelli; Alessandra Renieri; Francesca Ariani
Journal:  Eur J Hum Genet       Date:  2018-04-17       Impact factor: 4.246

7.  Low-penetrant RB allele in small-cell cancer shows geldanamycin instability and discordant expression with mutant ras.

Authors:  Yoonsoo Park; Akihito Kubo; Takefumi Komiya; Amy Coxon; Kristin Beebe; Len Neckers; Paul S Meltzer; Frederic J Kaye
Journal:  Cell Cycle       Date:  2008-05-30       Impact factor: 4.534

8.  Copy number variations and cancer.

Authors:  Adam Shlien; David Malkin
Journal:  Genome Med       Date:  2009-06-16       Impact factor: 11.117

9.  Signaling pathways involved in megakaryocyte-mediated proliferation of osteoblast lineage cells.

Authors:  Ying-Hua Cheng; Drew A Streicher; David L Waning; Brahmananda R Chitteti; Rita Gerard-O'Riley; Mark C Horowitz; Joseph P Bidwell; Fredrick M Pavalko; Edward F Srour; Lindsey D Mayo; Melissa A Kacena
Journal:  J Cell Physiol       Date:  2015-03       Impact factor: 6.384

10.  Germline mutations in retinoma patients: relevance to low-penetrance and low-expressivity molecular basis.

Authors:  Hana Abouzeid; Daniel F Schorderet; Aubin Balmer; Francis L Munier
Journal:  Mol Vis       Date:  2009-04-17       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.